切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 124 -127. doi: 10.3877/cma.j.issn.1674-3903.2021.02.013

综述

器官移植术后中枢神经系统脱髓鞘病变研究进展
卢如意1, 朱恒凯2, 刘相艳2, 郑树森2,()   
  1. 1. 杭州 310000,浙江树人大学树兰国际医学院附属树兰杭州医院神经内科
    2. 杭州 310000,浙江树人大学树兰国际医学院附属树兰杭州医院肝胆胰外科
  • 收稿日期:2020-01-08 出版日期:2021-04-25
  • 通信作者: 郑树森

Research advances in the demyelinating lesions of the central nervous system after organ transplantation

Ruyi Lu1, Hengkai Zhu2, Xiangyan Liu2, Shusen Zheng2,()   

  1. 1. Department of Neurology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310000, China
    2. Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou 310000, China
  • Received:2020-01-08 Published:2021-04-25
  • Corresponding author: Shusen Zheng
引用本文:

卢如意, 朱恒凯, 刘相艳, 郑树森. 器官移植术后中枢神经系统脱髓鞘病变研究进展[J]. 中华移植杂志(电子版), 2021, 15(02): 124-127.

Ruyi Lu, Hengkai Zhu, Xiangyan Liu, Shusen Zheng. Research advances in the demyelinating lesions of the central nervous system after organ transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(02): 124-127.

随着器官移植的快速发展,术后神经系统并发症的早期识别、诊断及治疗干预成为新的挑战。实体器官移植术后中枢神经系统脱髓鞘病变虽发生率低,但严重影响预后,临床上对其缺乏足够认识和重视。本文对器官移植术后中枢神经系统脱髓鞘病变相关研究进行归纳总结,以期提高临床医师的诊疗水平,帮助移植受者获得更佳的预后。

With the rapid development of organ transplantation, early identification, diagnosis and treatment of postoperative neurological complications have become a new challenge. Demyelinating lesions of the central nervous system is a complex complication after solid organ transplantation with low incidence but poor prognosis. This review summarized the research advances of postoperative demyelinating lesions in order to improve clinical practice, and provide recipients a better prognosis.

1
顾敏,廖中凯,石丽,等. 心脏移植术后神经系统并发症研究进展[J/CD]. 中华移植杂志:电子版,2020,14(4):255-257.
2
Weiss N, Thabut D. Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury[J]. Liver Transpl, 2019,25(3):469-487.
3
Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease[J]. Nat Rev Neurol, 2021,17(1):37-51.
4
Manz HJ, Dinsdale HB, Morrin PA. Progressive multifocal leukoencephalopathy after renal transplantation. Demonstration of Papova-like virions[J]. Ann Intern Med, 1971,75(1):77-81.
5
Moreno-Estébanez A, Almeida Velasco J, Pérez-Concha T, et al. Progressive multifocal leukoencephalopathy 11 years after liver transplantation: a case report[J]. J Neurovirol, 2017,23(6):929-931.
6
Rastogi A, Gulati N, Bihari Chhagan, et al. JC virus-related progressive multifocal leukoencephalopathy after living-donor liver transplant: A rare case[J]. Exp Clin Transplant, 2019,17(3):414-417.
7
Dumortier J, Guillaud O, Bosch A, et al. Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome[J]. Transpl Infect Dis, 2016,18(4):606-610.
8
Neff RT, Hurst FP, Falta EM, et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation[J]. Transplantation, 2008,86(10):1474-1478.
9
Lippa AM, Ocwieja KE, Iglesias J, et al. Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient[J]. Transpl Infect Dis, 2020,22(4):e13304.
10
Shitrit D, Lev N, Bar-Gil-Shitrit A, et al. Progressive multifocal leukoencephalopathy in transplant recipients[J]. Transpl Int, 2005,17(11):658-665.
11
Mateen FJ, Muralidharan R, Carone M, et al. Progressive multifocal leukoencephalopathy in transplant recipients[J]. Ann Neurol, 2011,70(2):305-322.
12
Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project[J]. Blood, 2009,113(20):4834-4840.
13
Windpessl M, Burgstaller S, Kronbichler A, et al. Progressive multifocal leukoencephalopathy following combined rituximab-based immune-chemotherapy for post-transplant lymphoproliferative disorder in a renal transplant recipient: a case report[J]. Transplant Proc, 2018,50(3):881-883.
14
Pavlovic D, Patera AC, Nyberg F, et al. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives[J]. Ther Adv Neurol Disord, 2015,8(6):255-273.
15
Ishii K, Yamamoto F, Homma S, et al. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review[J]. BMC Neurol, 2019,19(1):263.
16
Cortese I, Muranski P, Enose-Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy[J]. N Engl J Med, 2019,380(17):1597-1605.
17
Hoang E, Bartlett NL, Goyal MS, et al. Progressive multifocal leukoencephalopathy treated with nivolumab[J]. J Neurovirol, 2019,25(2):284-287.
18
Medrano C, Vergez F, Mengelle C, et al. Effectiveness of immune checkpoint inhibitors in transplant recipients with progressive multifocal leukoencephalopathy[J]. Emerg Infect Dis, 2019,25(11):2145-2147.
19
Lindzen E, Gilani A, Markovic-Plese S, et al. Acute disseminated encephalomyelitis after liver transplantation[J]. Arch Neurol, 2005,62(4):650-652.
20
Horowitz MB, Comey C, Hirsch W, et al. Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report[J]. Neuroradiology, 1995,37(6):434-437.
21
Kim SC, Jang HJ, Han DJ. Acute disseminated encephalomyelitis after renal transplantation in patients with positive Epstein-Barr virus antibody[J]. Transplant Proc, 1998,30(7):3139.
22
Iwanaga T, Ooboshi H, Imamura T, et al. A case of acute disseminated encephalomyelitis after renal transplantation[J]. Rinsho Shinkeigaku, 2001,41(11):792-796.[Article in Japanese]
23
Caucheteux N, Maarouf A, Daelman L, et al. Acute disseminated encephalomyelitis in two renal transplant patients: is there a role for Epstein-Barr virus reactivation?[J]. Mult Scler, 2013, 19(9):1222-1225.
24
Aboagye-Kumi M, Yango A Jr, Fischer S, et al. Acute disseminated encephalomyelitis in a renal transplant recipient: a case report[J]. Transplant Proc, 2008,40(5):1751-1753.
25
Lambeck J, Hieber M, Dreßing A, et al. Central pontine myelinosis and osmotic demyelination syndrome[J]. Dtsch Arztebl Int, 2019,116(35-36):600-606.
26
Morard I, Gasche Y, Kneteman M, et al. Identifying risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a case-control study[J]. Neurocrit Care, 2014,20(2):287-295.
27
Cascales Campos P, Ramirez P, Gonzalez R, et al. Central pontine and extrapontine myelinolysis: a rare and fatal complication after liver transplantation[J]. Transplant Proc, 2011,43(6):2237-2238.
28
Crivellin C, Cagnin A, Manara R, et al. Risk factors for central pontine and extrapontine myelinolysis after liver transplantation: a single-center study[J]. Transplantation, 2015,99(6):1257-1264.
29
Lee EM, Kang JK, Yun SC, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation[J]. Eur Neurol, 2009,62(6):362-368.
30
Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review[J]. Eur J Neurol, 2014,21(12):1443-1450.
31
Algahtani H, Shirah B, Alassiri A. Tumefactive demyelinating lesions: A comprehensive review[J]. Mult Scler Relat Disord, 2017,14:72-79.
32
Wan DL, Ren KW, Zhang LL, et al. Liver transplant recipient with tumefactive demyelinating lesions: A case report and literature review[J]. Transplant Proc, 2016,48(9):3197-3202.
[1] 中国肝移植注册中心, 国家肝脏移植质控中心, 国家人体捐献器官获取质控中心, 国家骨科与运动康复临床医学研究中心, 中国医师协会器官移植医师分会移植器官质量控制专业委员会中国医院协会器官获取与分配工作委员会, 国家创伤医学中心器官保护专业委员会. 中国移植器官保护专家共识(2022版)[J]. 中华普通外科学文献(电子版), 2022, 16(04): 241-254.
[2] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[5] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[6] 艾紫叶, 李玲, 何重香, 黄伟, 叶啟发. 猪器官异种移植研究进展[J]. 中华移植杂志(电子版), 2023, 17(03): 186-191.
[7] 杨锦然, 李新长, 何小平, 傅俊, 龙成美, 陈志铭. 不破坏膈肌式肝肾联合获取术总结分析[J]. 中华移植杂志(电子版), 2023, 17(03): 146-151.
[8] 刘剑戎, 范明明, 郭煜. 器官捐献者转介时的临床特征分析[J]. 中华移植杂志(电子版), 2023, 17(03): 129-133.
[9] 国家传染病医学中心, 中华医学会器官移植学分会, 中国康复医学会器官移植康复专业委员会, 中国器官移植发展基金会器官移植受者健康管理专项基金. 实体器官移植受者新型冠状病毒感染诊疗专家共识(2023年版)[J]. 中华移植杂志(电子版), 2023, 17(02): 65-81.
[10] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 心肾联合移植三例[J]. 中华移植杂志(电子版), 2023, 17(02): 124-127.
[11] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 新型冠状病毒感染流行下我国器官捐献者筛选规则是否应时而变?[J]. 中华移植杂志(电子版), 2023, 17(02): 82-88.
[12] 中国器官移植发展基金会器官移植受者健康管理专家委员会. 器官移植受者新型冠状病毒感染防治策略与健康管理中国专家指导意见(第一版)[J]. 中华移植杂志(电子版), 2023, 17(01): 1-12.
[13] 中国医师协会器官移植医师分会, 中华医学会器官移植学分会. 中国实体器官移植手术部位感染管理专家共识(2022版)[J]. 中华移植杂志(电子版), 2022, 16(03): 129-139.
[14] 任明仕, 王嵘, 王明岩, 张丽月, 成楠, 吴远斌. 异种心脏移植基因修饰策略及围手术期管理研究进展[J]. 中华移植杂志(电子版), 2022, 16(03): 183-189.
[15] 贺海燕, 谢文照. 公民自愿捐献器官的家庭文化模式初步探讨[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1269-1275.
阅读次数
全文


摘要